Anthony Schena, MD
Sports Medicine · Brighton, MANPI 1952398174
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $45,644 of the $56,619 with a category attached, or 80.6%. Anika Therapeutics, Inc. accounts for 91.4% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2020 at $45,998 and has fallen 99.7% since, to $153 in 2025. Among sports medicine clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 96 payments — averaging $589.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Anika Therapeutics, Inc.$52K
- Stryker$1K
- Arthrex$846
- Smith+Nephew$508
- Pacira Pharmaceuticals Incorporated$486
- Heron Therapeutics, Inc.$333
- plus $2K from 13 others
What the payments were for
- Consulting fees$2250%
- Travel & lodging$6381%
- Food & beverage$4,1367%
- Ownership interest$45,64481%
- Other$5,97611%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Anika Therapeutics, Inc. | 5 | $51,773 |
| Stryker(2 entities) | 11 | $1,082 |
| Arthrex | 14 | $846 |
| Smith+Nephew | 10 | $508 |
| Pacira Pharmaceuticals Incorporated | 11 | $486 |
| Heron Therapeutics, Inc. | 4 | $333 |
| Arteriocyte Medical Systems, Inc. | 1 | $261 |
| Depuy Synthes Products, Inc. | 1 | $225 |
| Ferring Pharmaceuticals Inc. | 12 | $218 |
| Bioventus LLC | 9 | $213 |
| Orthofix Medical, Inc. | 2 | $168 |
| Pacira Therapeutics, Inc. | 5 | $159 |
| Avanos Medical | 1 | $117 |
| Johnson & Johnson | 4 | $88 |
| Fidia Pharma USA Inc. | 2 | $41 |
| DJO, LLC | 1 | $35 |
| Kairos Surgical Inc | 1 | $27 |
| Abbott | 1 | $25 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$437
- Physio-Stim$264
- Magellan$261
- Zynrelef$252
- IOVERA SYSTEM$223
- Regeneten$165
- TACTOSET$153
- N/A$137
- ACL/PCL FLEXIBLE INSTRUMENTATION$135
- HIP ARTHROSCOPY ACCESS & INSTRUMENTATION SET$135
- ON-Q* PUMP AND ACCESSORIES$117
- Iovera$111
How this compares
$56,619 in reported general payments places this provider in the 90th percentile of 138 sports medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 20 | $406 |
| Ibuprofen | 18 | $220 |
| Celecoxib | 13 | $157 |
| Omeprazole | 11 | $112 |
| Oxycodone Hcl | 24 | $98 |
| Meloxicam | 48 | $80 |
| Amoxicillin | 41 | $53 |
| Tramadol Hcl | 17 | $32 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Brighton
- Sarav ShahBrighton$90K
- Kathryn AckermanBrighton$5K
- Brian BusconiWorcester$684K
- Thomas WuerzWaltham$464K
- Elizabeth MatzkinBoston$182K
- Thomas GillDedham$168K
- Xinning LiBoston$109K
- Joseph CzarneckiWoburn$93K
- Miho TanakaBoston$89K
- James OholleranPeabody$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.